Side by side
10.0/107 of 7 scored disclosures publishedBest for: buyers who will use group nutrition support and compare the supply term as carefully as the monthly equivalent
$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule.
5.7/104 of 7 scored disclosures publishedBest for: Spanish-speaking patients who want one fixed price for a full year of treatment
$199/moper month on a 52-week plan
At a glance
| Compared on | Belle Health | REMEVi |
|---|---|---|
| Pricing structure | Belle HealthDose-independent pricing within the selected compounded supply plan; longer supplies have lower monthly equivalents | REMEViOne rate per drug, holding at every dose |
| Plan commitment | Belle HealthOne-, two-, six- and twelve-month supplies for both compounded drugs; the lowest equivalents require twelve months | REMEViA fifty-two week plan for the advertised rates; month-to-month costs more on both drugs |
| Compounding pharmacy | Belle HealthMore than one named on the site | REMEViNot named; described as verified by NPI number |
| Language of care | Belle HealthNot published as a bilingual program | REMEViClinicians treat patients directly in Spanish as a primary language, not through translation |
| What the membership adds | Belle HealthWeekly live group coaching with a registered dietitian, alongside clinician and nurse support | REMEViThe rate holds for the full course of treatment rather than rising with the dose |
| Third-party credentials shown | Belle HealthNo accreditation seal published | REMEViDisplays a LegitScript seal, which shows a seal is published rather than who holds the certificate |
| Regulatory disclosures | Belle HealthOne FDA warning letter, February 2026, about how Belle's site presented Belle branding beside the compounded drugs it sells | REMEViNo FDA warning letter |
| States served | Belle HealthAll fifty states | REMEViAll fifty states plus DC |
| Brand-name option | Belle HealthCurrent disclosures include approved brands as well as compounded options; obtain a product-specific quote | REMEViNone published |
| Disclosure score | Belle Health10.0/10 | REMEVi5.7/10 |
What each one publishes
| Medication | Belle Health | REMEVi |
|---|---|---|
| Semaglutide (compounded) | Belle Health$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule.twelve-month supply; all doses · Verified October 2026 — $199/moPublished one-month supply price with care, supplies and shipping included; no separate membership fee.one-month supply; all doses · Verified October 2026 — | REMEVi$199/moper month on a 52-week planflat rate, all doses · Verified August 2026 — |
| Tirzepatide (compounded) | Belle Health$179Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $199, two-month rate $219, one-month rate $249. Confirm the upfront payment and refill schedule.twelve-month supply; all doses · Verified October 2026 — $249/moPublished one-month supply price with care, supplies and shipping included; no separate membership fee.one-month supply; all doses · Verified October 2026 — | REMEVi$269/moper month on a 52-week planflat rate, all doses · Verified August 2026 — |
Lower equivalents come with longer terms
Belle’s current compounded pricing offers one-, two-, six- and twelve-month supplies for both semaglutide and tirzepatide. Longer supplies reduce the monthly equivalent, with the lowest equivalents tied to twelve months. Neither drug should be described as having a universally unbundled lowest rate.
REMEVi’s recorded advertised rates require a fifty-two-week plan; month-to-month options cost more. A lower monthly equivalent at either service should be compared with the total amount committed.
Belle says the selected price holds across doses and includes medication, injection supplies, shipping and care, without a separate membership fee. Compare the full payment commitment and renewal schedule, not just an equivalent monthly figure.
Language and care support
REMEVi’s published model provides clinical care in Spanish rather than only translating its website. That can matter when discussing symptoms, side effects and treatment changes.
Belle includes weekly live group coaching with a registered dietitian. This is not a promise of an individual weekly appointment; consider whether you would use the group format.
Belle does not publish an equivalent Spanish-language program in the evidence used here. Ask about the language of clinical appointments if it matters to your care.
Pharmacy names and product choices
Belle names compounding pharmacy partners. REMEVi’s recorded disclosure describes NPI verification without identifying a dispensing pharmacy; ask which will fill your prescription.
Belle’s current disclosures describe approved brand-name options alongside compounded treatment. Confirm the exact medication and its quote. A compounded product is not interchangeable with an FDA-approved finished drug.
The REMEVi evidence used in this comparison does not identify a brand-name option. Confirm current availability if an approved product is essential to your decision.
Belle’s FDA warning letter
FDA warning letter No. 721795, issued in February 2026, found Belle’s products misbranded because its presentation misleadingly suggested Belle compounded the drugs. The letter remains relevant even though this comparison now reflects newer commercial information.
The letter does not establish the contents of an individual vial, and current website changes do not establish that FDA has accepted a resolution. Read the linked agency document when weighing the provider.
Boards both of these appear on
Belle Health and REMEVi both qualify for 4 of the 6 boards on this site. Each board ranks a wider field than these two, so a position here is against everyone on it, not against each other.
- Semaglutide — Belle Health #26, REMEVi #110, of 334
- Tirzepatide — Belle Health #25, REMEVi #103, of 319
- Cheapest Overall — Belle Health #28, REMEVi #121, of 396
- Cash Pay vs Insurance — Belle Health #8, REMEVi #52, of 80
Who each one is better for
Belle Health
- Buyers who want named pharmacy partners.
- People comparing shorter supplies against a twelve-month lowest-equivalent plan.
- Readers interested in included weekly group coaching or disclosed brand-name options.
REMEVi
- Spanish-speaking patients who want to discuss side effects and progress with the clinician directly, not through an interpreter or a translated form.
- Readers confident they will stay on treatment for a full course and who want one fixed price for the whole year.
- Patients in smaller markets, since coverage runs to all fifty states plus DC.
Frequently asked questions
Does Belle require only three months at most?
No. Its current compounded choices run from one to twelve months for both drugs, and the lowest monthly equivalents require twelve months.
What distinguishes REMEVi’s care?
Its published service offers clinical care in Spanish. Belle does not publish an equivalent in the evidence used here.
Does Belle offer only compounded medication?
No. Current Belle disclosures include approved brands. Ask for the specific product and full quote.
Which provider names compounding pharmacies?
Belle names pharmacy partners. REMEVi’s recorded materials describe NPI verification without naming a dispensing partner.